Rockford, Ill.-based Mercyhealth has opened a retail pharmacy in Beloit, Wis., expanding prescription access for patients on the Illinois-Wisconsin border.  The pharmacy offers prescription filling, medication counseling, prescription transfers and refill services. A drive-thru lane is available for patients seeking…

In April, the FDA debuted a real-time clinical trial model that will allow the agency to monitor safety signals as the trial is being conducted. The first trials were launched in partnership with Houston-based University of Texas MD Anderson Cancer…

Researchers at the University of California, Irvine, have found that some antibody-drug conjugates, an emerging class of targeted cancer therapies, were associated with serious infection-related complications, including hospitalization and intensive care admissions. The study analyzed treatment data from 3,511 patients…

The 340B Drug Pricing Program is under pressure from multiple directions: pharmacy benefit manager litigation, drugmaker contract pharmacy restrictions, and a federal rebate pilot that courts have effectively killed. For health systems, the program represents one of the most significant…

Rockford, Ill.-based Mercyhealth has opened a new pharmacy in Beloit, Wis., expanding access to prescription services for patients in the community, according to a June 2 report from WIFR. Mercyhealth Pharmacy-Beloit is one of 11 pharmacies operated by the health…

The FDA has issued a complete response letter for Cingulate’s new drug application seeking approval of CTx-1301 for the treatment of attention-deficit/hyperactivity disorder. The agency’s response identified specific Chemistry, Manufacturing and Controls information requests and did not raise any current…

Madison, Wis.-based UW Health has expanded its prescription delivery service, offering free next-day home delivery for patients in Dane County, Wis. The health system has provided home prescription delivery since 2012, but deliveries previously took several days through carriers such…

At a time when healthcare executives are being asked to stretch scarce federal resources as far as possible, the 340B Drug Pricing Program is a much-appreciated lifeline. Despite the program being around for over three decades, the need for its…

Eli Lilly has given some 340B hospitals five business days to begin submitting claims-level data or risk losing access to discounted drug pricing, escalating a growing dispute over transparency requirements in the federal drug discount program. In a June 1…

About $300 billion in revenue generated by rated pharmaceutical companies is expected to face generic and biosimilar competition through 2031 — a shift with direct implications for how hospitals and health systems manage their drug budgets over the next several…